Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Warmuth Markus sold 5,466 Monte Rosa Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 2, 2026

On Jun 1, 2026, Warmuth Markus (Director, President & CEO) sold 5,466 Monte Rosa Therapeutics, Inc. shares at an average US$19.44 for US$106K under a trading plan, leaving 594,538 shares. Filed Jun 2, 2026 (Form 4).

Sold
5,466 shares
Price
US$19.44 average (US$19.41 to US$19.73)
Value
US$106K
Holding after
594,538 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockSale4,998US$19.41595,006Direct
Jun 1, 2026Common StockSale468US$19.73594,538Direct

Source

View original at SEC

Related